Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL11797700 | 1.00 | KDM4E (0.43) | KDM4EHSD17B10TSHRALOX15GAA | |
| Sulfuric Acid SCHEMBL2073978 | 0.98 | KDM4E (0.42) | KDM4EHSD17B10TSHRALOX15GAA | |
| Tetramethylammonium Ion SCHEMBL8829717 | 0.86 | L3MBTL1 (0.42) | KDM4EHSD17B10TSHRALOX15GAA | |
| SCHEMBL8135220 | 0.85 | — | — | |
| SCHEMBL3167 | 0.85 | — | — | |
| Fluoride SCHEMBL7750159 | 0.85 | — | — | |
| SCHEMBL28231022 | 0.85 | USP2 (0.46) | KDM4EHSD17B10TSHRALOX15GAA | |
| SCHEMBL474212 | 0.85 | — | — | |
| Fluoride SCHEMBL11426086 | 0.85 | USP2 (0.46) | KDM4EHSD17B10TSHRALOX15GAA | |
| SCHEMBL15265769 | 0.85 | USP2 (0.46) | KDM4EHSD17B10TSHRALOX15GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090045059-A1 | Method and apparatus for measuring membrane potential of red blood cells using electrophoretic analysis | SUN PLASTICS CO., LTD. (JP) | 2009-02-19 | — | — | US | claimed |
| CN-114182526-B | Clothing cool spray and preparation method thereof | 广东好顺欧迪斯科技股份有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-109633161-B | Procalcitonin detection kit based on latex enhanced immunoturbidimetry | 深圳上泰生物工程有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-111787954-A | Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopatadine | 格兰马克专业公司 | 2020-10-16 | — | — | CN | disclosed |
| CN-110806487-A | Kit for detecting human heparin binding protein and preparation method thereof | 深圳上泰生物工程有限公司 | 2020-02-18 | — | — | CN | disclosed |
| CN-110650744-A | Functional scaffold for promoting meniscus repair | 斯克里普斯研究学院 | 2020-01-03 | — | — | CN | disclosed |
| EP-3231417-B1 | STORAGE STABLE, OPHTHALMIC COMPOUND | DR GERHARD MANN CHEM PHARM FABRIK GMBH (DE) | 2018-12-05 | — | — | EP | disclosed |
| US-10106805-B2 | Manipulating fructan biosynthesis and enhancing plant biomass | AGRICULTURE VICTORIA SERVICES PTY LTD. (AU) | 2018-10-23 | — | — | US | disclosed |
| WO-2018170484-A1 | FUNCTIONALIZED SCAFFOLD TO PROMOTE MENISCUS REPAIR | THE SCRIPPS RESEARCH INSTITUTE (US) | 2018-09-20 | — | — | WO | disclosed |
| WO-2017178544-A1 | STORAGE-STABLE OPHTHALMIC COMPOSITION | DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH (DE) | 2017-10-19 | — | — | WO | disclosed |
| EP-1929303-B1 | ASSAY AND KITS THEREFOR | ANIMAL HEALTH INST (GB) | 2010-11-24 | — | — | EP | disclosed |
| US-20100210015-A1 | PHOTOCHEMICAL ACTIVATION OF SURFACES FOR ATTACHING BIOMATERIAL | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2010-08-19 | — | — | US | disclosed |
| US-7635734-B2 | Photochemical activation of surfaces for attaching biomaterial | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2009-12-22 | — | — | US | disclosed |
| US-20090045059-A1 | Method and apparatus for measuring membrane potential of red blood cells using electrophoretic analysis | SUN PLASTICS CO., LTD. (JP) | 2009-02-19 | — | — | US | disclosed |
| EP-1929303-A2 | ASSAY AND KITS THEREFOR | Institute for Animal Health (GB) | 2008-06-11 | — | — | EP | disclosed |
| US-20080064863-A1 | Conjugate of Peo and Double Stranded Nucleic Acid | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-03-13 | — | — | US | disclosed |
| EP-1801210-A1 | CONJUGATE OF PEO WITH DOUBLE-STRANDED NUCLEIC ACID | Japan Science and Technology Agency (JP) | 2007-06-27 | — | — | EP | disclosed |
| US-20060147413-A1 | Photochemical activation of surfaces for attaching biomaterial | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-07-06 | — | — | US | disclosed |
| WO-2006000740-A2 | ASSAY AND KITS THEREFOR | INSTITUTE FOR ANIMAL HEALTH (GB) | 2006-01-05 | — | — | WO | disclosed |
| US-4851035-A | Composition for inhibition of ethylene production in plants | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, STANFORD UNIVERSITY (US) | 1989-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060147413-A1 | Photochemical activation of surfaces for attaching biomaterial | ITGAL, ITGA6, CRYAA | KDM4E 2460/4885HSD17B10 4611/4885TSHR 4317/4885 |
| US-20080064863-A1 | Conjugate of Peo and Double Stranded Nucleic Acid | POLI, POLRMT, POLN | KDM4E 4317/4885HSD17B10 3033/4885TSHR 4114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.